Amsterdam, Netherlands – In a significant corporate announcement, Royal Philips (NYSE: PHG, AEX: PHIA), a forefront runner in health technology, revealed its decision to appoint Charlotte Hanneman as the Chief Financial Officer (CFO), starting October 1, 2024. This strategic move is aligned with Philips’ vision for future growth and innovation, marking the beginning of a new chapter in its illustrious history.
Charlotte Hanneman, renowned for her extensive experience in the MedTech and pharmaceutical sectors, is poised to join the Philips’ Executive Committee on June 1, 2024, initiating her transition period. She succeeds the esteemed Abhijit Bhattacharya, who has been instrumental in Philips’ transformation over his 37-year tenure, and is set to retire on September 30, 2024.
Hanneman’s career includes pivotal roles at Stryker, where she excelled as Controller and Head of Financial Planning & Analysis, demonstrating profound leadership in financial control and business development finance across multiple regions. Her prior experiences at leading healthcare companies like Merck, Schering-Plough, and Organon have equipped her with a rich global perspective, making her an invaluable asset to Philips.
Roy Jakobs, CEO of Royal Philips, expressed deep gratitude towards Bhattacharya for his dedication and significant contributions to the company. He enthusiastically welcomed Hanneman, highlighting her robust industry knowledge, financial expertise, and passion for healthcare innovation as key factors making her the ideal candidate for the role.
Echoing the sentiment of excitement, Charlotte Hanneman shared her enthusiasm for joining Philips at a pivotal time, aiming to leverage its global influence and innovative capabilities to effect meaningful change in healthcare.
Feike Sijbesma, Chairman of Philips’ Supervisory Board, commended Bhattacharya’s remarkable career and welcomed Hanneman’s addition to the team, emphasizing the enhanced diversity and deepened industry expertise she brings to the Board of Management.
As Philips continues to navigate through a landscape of healthcare innovation and sustainable impact, the appointment of Charlotte Hanneman as CFO signifies a strategic step towards reinforcing its leadership position in the global market.
